Search research articles
Contact Us
Filters
Showing results (221-230 of 376) with videos related to
Page
of 38
Sort By:
Archives of Cardiovascular Diseases
|
January 10, 2019
Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR)
Anne Godier, Dephine Garrigue, Dominique Lasne, et al.
Lancet (London, England)
|
December 26, 2008
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
Jean-Philippe Collet, Jean-Sébastien Hulot, Anna Pena, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
October 14, 2017
2017 EACTS Guidelines on perioperative medication in adult cardiac surgery
Miguel Sousa-Uva, Stuart J Head, Milan Milojevic, et al.
Archives of Cardiovascular Diseases
|
December 22, 2022
Beta-blocker prescription and outcomes in uncomplicated acute myocardial infarction: Insight from the ePARIS registry
Gaspard Suc, Michel Zeitouni, Niki Procopi, et al.
Journal of the American College of Cardiology
|
December 22, 2018
Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial Infarction
Maryse Guerin, Johanne Silvain, Julie Gall, et al.
Archives of Cardiovascular Diseases
|
August 12, 2009
Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial
Jean-Philippe Collet, Gilles Montalescot, Philippe Gabriel Steg, et al.
The Canadian Journal of Cardiology
|
April 3, 2022
Outcomes Following Patent Foramen Ovale Percutaneous Closure According to the Delay From Last Ischemic Event
Paul Guedeney, Jules Mesnier, Michel Zeitouni, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 5, 2022
ESC/EAS guidelines for the detection, prevention, and treatment of individuals at risk of a first myocardial infarction: effect of 5 years of updates and the new SCORE2
David Sulman, Michel Zeitouni, Johanne Silvain, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
August 26, 2018
Biomarkers of Thrombosis in ST-Segment Elevation Myocardial Infarction: A Substudy of the ATOLL Trial Comparing Enoxaparin Versus Unfractionated Heparin
Johanne Silvain, Stephen A O'Connor, Yan Yan, et al.
International Journal of Cardiology
|
July 2, 2011
Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors
Olivier Barthélémy, Tobias Limbourg, Jean Philippe Collet, et al.
Page
of 38
Search research articles
Search
Showing results (221-230 of 376) with videos related to
Sort By:
Page
of 38
Archives of Cardiovascular Diseases
|
January 10, 2019
Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR)
Anne Godier, Dephine Garrigue, Dominique Lasne, et al.
Lancet (London, England)
|
December 26, 2008
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
Jean-Philippe Collet, Jean-Sébastien Hulot, Anna Pena, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
October 14, 2017
2017 EACTS Guidelines on perioperative medication in adult cardiac surgery
Miguel Sousa-Uva, Stuart J Head, Milan Milojevic, et al.
Archives of Cardiovascular Diseases
|
December 22, 2022
Beta-blocker prescription and outcomes in uncomplicated acute myocardial infarction: Insight from the ePARIS registry
Gaspard Suc, Michel Zeitouni, Niki Procopi, et al.
Journal of the American College of Cardiology
|
December 22, 2018
Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial Infarction
Maryse Guerin, Johanne Silvain, Julie Gall, et al.
Archives of Cardiovascular Diseases
|
August 12, 2009
Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial
Jean-Philippe Collet, Gilles Montalescot, Philippe Gabriel Steg, et al.
The Canadian Journal of Cardiology
|
April 3, 2022
Outcomes Following Patent Foramen Ovale Percutaneous Closure According to the Delay From Last Ischemic Event
Paul Guedeney, Jules Mesnier, Michel Zeitouni, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
April 5, 2022
ESC/EAS guidelines for the detection, prevention, and treatment of individuals at risk of a first myocardial infarction: effect of 5 years of updates and the new SCORE2
David Sulman, Michel Zeitouni, Johanne Silvain, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
August 26, 2018
Biomarkers of Thrombosis in ST-Segment Elevation Myocardial Infarction: A Substudy of the ATOLL Trial Comparing Enoxaparin Versus Unfractionated Heparin
Johanne Silvain, Stephen A O'Connor, Yan Yan, et al.
International Journal of Cardiology
|
July 2, 2011
Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors
Olivier Barthélémy, Tobias Limbourg, Jean Philippe Collet, et al.
Page
of 38